Cronyn Verschoyle, Howard John, Chiang Leslie, Le Lisa, Tims-Cook Zandraetta, Gertz Alida M
Wellstar Atlanta Medical Center Family Med Residency Program, 1000 Corporate Center Drive, Suite 200, Morrow 30260, GA, USA.
Medical College of Georgia, Augusta, GA, USA.
Case Rep Infect Dis. 2021 Dec 17;2021:6841393. doi: 10.1155/2021/6841393. eCollection 2021.
is a yeast-like basidiomycete that is an emerging opportunistic infection in immunocompromised patients. Urinary tract infections due to are rarely reported in the literature and typically seen only in immunocompromised patients. In addition to being immunocompromised, critically ill COVID-19 patients often have prolonged exposure to antibiotics, corticosteroids, and Foley catheters, which further increases their susceptibility to infection with There are limited case reports documenting successful treatment of among hospitalized patients, particularly among COVID-19 patients, in the literature. Therefore, it is important that successful treatment regimens be reported. Here, we report a case of urinary tract infection successfully treated with fluconazole and voriconazole in a 73-year-old male recovering from COVID-19. Urinary tract infections with should be considered in persistently febrile COVID-19 patients with fungal urinary tract infections since prompt recognition and treatment can reduce the risk of disseminated disease and early mortality.
是一种酵母样担子菌，是免疫功能低下患者中新兴的机会性感染病原体。文献中关于由其引起的尿路感染报道很少，通常仅见于免疫功能低下患者。除了免疫功能低下外，危重症COVID-19患者常长期使用抗生素、皮质类固醇和留置导尿管，这进一步增加了他们感染的易感性。文献中记录住院患者，尤其是COVID-19患者中成功治疗该病原体感染的病例报告有限。因此，报告成功的治疗方案很重要。在此，我们报告一例73岁正在从COVID-19中康复的男性患者，其尿路感染用氟康唑和伏立康唑成功治疗。对于持续发热且有真菌性尿路感染的COVID-19患者，应考虑由该病原体引起的尿路感染，因为及时识别和治疗可降低播散性疾病风险和早期死亡率。
